PPT-Treatment of HCV Coinfection

Navigating the Interactions Jennifer J Kiser PharmD Assistant Professor Department of Pharmaceutical Sciences University of Colorado School of Pharmacy From JJ Kiser MD at Chicago IL May 20 2013 IASUSA . Mark Sulkowski, MD . Professor of Medicine. Medical Director, Viral Hepatitis Center. Divisions of Infectious Diseases and Gastroenterology/ Hepatology. Johns Hopkins Medical Institutions. Baltimore Maryland USA. Bruno Spire & Patrizia Carrieri. How to reduce HCV incidence among people who use drugs?. Increasing access to effective treatment for opioïd dependence (e.g. methadone). Diversifying harm reduction tools for safer drug consumption . C-EDGE Treatment Naïve (TN). Phase 3. . Treatment. . Naïve. Zeuzem. S, . et al. . Ann Intern Med. 2015;163:1-13.. Source: . Zeuzem. S, et al. Ann Intern Med. 2015;163:1-13. .. Elbasvir-Grazoprevir.  . current practice and future capacity.. Vendula. Belackova. 1. Allison Salmon. 1. Eberhard Schatz. 2. Marianne . Jauncey. 1. William Wood. 1. International Network of . Drug Consumption Rooms. 1. . Case. 47-Year-Old . Man With Asymptomatic HIV Infection. Case (cont). Initial Clinical Presentation. Laboratory Results. HepaScore. ®. A Composite Biomarker Panel for Liver Fibrosis. Hepatic Steatosis in Patients With HIV/HCV Coinfection. Isabelle Andrieux-Meyer, MD. Médecins Sans Frontières . IAS Kuala Lumpur, July 2. nd. 2013. . Prevention strategies for HIV/HCV co infection. Epidemiological burden of HCV/HIV co-infection. Access to HCV screening. Strategies To Identify and Advance PWID HCV Patient Care. Linkage to C Care Program. . Imtiaz Alam, M.D.. Medical Director, Austin Hepatitis Center. Medical Director, . HepCare. Specialty Pharmacy. University of Chicago. Chicago, Illinois. Challenges in the Management and Treatment of HIV/Hepatitis C Virus Coinfection. FORMATTED: 05/02/2016. Chicago, Illinois: May 9, 2016. From . AI . Aronsohn. IAPAC African Regional Capacity-Building Hub. Based in Johannesburg, South Africa. Mission: Strengthen clinician capacity to deliver HIV, HBV, and HCV treatment . Partners include:. . Supported through an educational grant from: . HepCare Europe No-one gets left behind: addressing the hidden burden of HCV related advanced liver disease in PWID in the community Dr John Lambert, Professor of Medicine and Consultant in Infectious Diseases, Mater Hospital and UCD Dublin Todd S. Wills, MD. Martha Friedrich, PhD. SPNS Hepatitis C Treatment Expansion Initiative. University of South Florida. The HIV/HCV Disease Burden. Hepatitis C. In U.S., 4 million HCV+ . →. 85% chronic . with Direct-Acting Antivirals (DAAs). www.hcvguidelinesny.org. Purpose of this Guideline. Promote universal screening for HCV.. Increase . the number of NYS residents with chronic HCV infection treated for and cured of HCV. . Hansen Dang,. 1,2*. Yee Hui Yeo,. 1*. Satoshi Yasuda,. 3. Chung-Feng Huang,. 4. Etsuko Iio,. 5. Charles Landis,. 6. Dae Won Jun,. 7. Masaru Enomoto,. 8. Eiichi Ogawa,. 9. Pei-. Chien. Tsai,. Dr. Sonalika’s Eye Clinic provide the best Eye infection treatment, Conjunctivitis treatment in pune, Hadapsar, Amanora, Magarpatta, Mundhwa, Kharadi Rd, Viman Nagar, Wagholi, and Wadgaon Sheri